Trials / Sponsors / Auron Therapeutics, Inc.
Auron Therapeutics, Inc.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS Relapsed Acute Myeloid Leukemia (AML), Refractory Acute Myeloid Leukemia (AML), Relapsed/Refractory AML | Phase 1 | 2025-05-01 |